Scott Fitzpatrick, PhD, is the Senior Director of Clinical Sciences at Kodiak Sciences, a position they have held since 2025. Previously, they served in various roles at Bayer Pharmaceuticals from 2019 to 2022, including Deputy Director of Global MSL Strategy Communications and Training for Ophthalmology. Earlier in their career, Scott was a Biomaterials Scientist at Covalon Technologies and led the Medical Science Liaison team for Bayer, actively participating in innovation councils. Scott also held an Adjunct Assistant Professor position at Queen's University and gained research experience at McMaster University, where they earned their PhD in Biomedical Engineering. Their expertise spans biomaterial synthesis, drug delivery, and regenerative medicine.
This person is not in the org chart
This person is not in any teams
This person is not in any offices